This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: F. Hoffmann-La Roche Ag, Prothena Biosciences Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 181 
1 out of 64 
Years Active: 2026
Title: Sara Belli: Innovator in Synucleinopathies Treatment
Introduction
Sara Belli is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of medical research, particularly in the treatment of synucleinopathies. Her innovative work has led to the development of a patent that addresses critical aspects of dosing regimens for these complex conditions.
Latest Patents
Sara Belli holds a patent titled "Dosing Regimes for Treatment of Synucleinopathies." This patent represents her commitment to advancing medical treatments and improving patient outcomes. She has successfully secured 1 patent that showcases her expertise and dedication to innovation in healthcare.
Career Highlights
Throughout her career, Sara has worked with notable companies, including F. Hoffmann-La Roche AG and Prothena Biosciences Limited. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Sara has collaborated with talented individuals such as Jay Soto and Daniel Keith Ness. These partnerships have enriched her work and fostered an environment of innovation and creativity.
Conclusion
Sara Belli is a remarkable inventor whose work in the treatment of synucleinopathies has the potential to transform patient care. Her dedication to innovation and collaboration highlights the importance of research in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile